9
Apr
2025
What US Biotech Can Do to Meet the Moment
We have entered a new era in biotech. Turmoil at the FDA has introduced new uncertainty. NIH funding cuts and grant delays have led to academic institutions to hold off on job offers to young scientists. The Trump Administration’s reset of trade relations with the world caused a financial market meltdown, and wild rebound. All of these things are... Read More
8
Jan
2025
How the US Can Continue to Lead As China Rises
China made its intentions known 10 years ago. In the “Made in China 2025” plan, released in 2015, the government identified biopharmaceuticals as one of the industries where it sought a world leadership position. The investment has paid off. By making biotech a top priority, the China biotech ecosystem is now thriving. As we enter 2025, the strength of China’s... Read More